Researchers found that adults with depression who started taking these medications had a higher risk of death compared ...

The specialist has just published a book that reviews the benefits and risks of medications for mental illnesses ...

The biotech reported progress on its lead molecule and out-licensed two candidates, amid cash constraints and a potential ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

New scientific research on how the brain maintains stability amidst continuous environmental and physiological changes offers ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, ...

Shields’s confession of postpartum depression reached an enormous audience, mainly because actor Tom Cruise publicly ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...

Better understanding of the complex relationship between mind and body may provide new treatment strategies for chronic pain, ...